Accessibility: Skip TopNav
Figure 1
Atacicept 72-week Data From the Phase 2b ORIGIN Trial Are Consistent With a Profile of True Disease Modification
Format
PNG
Quelle:
Vera Therapeutics
Downloads
Originalgröße
Groß
Mittel
Klein